08 March 2017
Maryland
Reporter: Barney Dixon
Supernus secures settlements with generics manufacturers
Supernus Pharmaceuticals has settled with drug makers Actavis and Zydus, securing a significant delay in the release of their generic versions of Trokendi XR capsules for partial onset seizures and primary generalised tonic-clonic seizures.

Actavis, a subsidiary of Teva Pharmaceuticals, and Zydus sought approval to market generic versions of Trokendi XR, prompting patent infringement complaints from Supernus.

The settlements bind Actavis and Zydus to release dates for their generic versions in 2023, or earlier, under certain, undisclosed circumstances.

Supernus said in statement that it will continue its “vigorous enforcement of its patent rights” for the drug, which expire in 2027.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Microsoft and Toyota connect over cars
23 March 2017 | Washington | Reporter: Barney Dixon
The deal will consolidate Microsoft software and Toyota hardware
IPO Pakistan and SIPO agree to MOU
23 March 2017 | Islamabad | Reporter: Barney Dixon
The deal will ensure high levels of cooperation in patent examination
SCOTUS weakens laches as a defence
22 March 2017 | Washington DC | Reporter: Barney Dixon
Laches cannot be invoked as a defence against a claim for damages brought within the six-year limitations period, according to a new ruling from the US Supreme Court
USITC to investigate LG
21 March 2017 | Washington DC | Reporter: Barney Dixon
The US International Trade Commission has instituted an investigation into four technology companies, including LG
IPSO asks Germany to step into EPO dispute
21 March 2017 | Munich | Reporter: Barney Dixon
The International and European Public Services Organisation has penned a letter to German Chancellor Angela Merkel raising its “extreme concern” with the European Patent Office
Lewis Roca Rothgerber hires of counsel
21 March 2017 | Los Angeles | Reporter: Barney Dixon
Lewis Roca Rothgerber Christie has hired Holly Logue as of counsel in its intellectual property practice group
SCOTUS to decide patent exhaustion question
20 March 2017 | Washington DC | Reporter: Barney Dixon
The US Supreme Court will hear oral arguments tomorrow (21 March) in the much-anticipated Impression Products v Lexmark International litigation, as justices grapple with one of the more uncertain areas of US patent law